TFF PHARMACEUTICALS, INC. Proceeds from Stock Options Exercised
TFF PHARMACEUTICALS, INC. reported Proceeds from Stock Options Exercised of $110.82 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-03-28
- TFF PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2022-12-31 was $100.64K.
- TFF PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2022-09-30 was $0.00.
- TFF PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2022 was $110.82K, a 38.50% decline from fiscal 2021.
- TFF PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2021 was $180.21K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-12-31 | $100.64K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $100.64K derived: sum of 2 quarters · filed 2024-03-28 | $110.82K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $10.19K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $10.19K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $180.21K 10-K · filed 2023-03-31 |